Suppr超能文献

日本骨关节炎和慢性下腰痛患者的药物治疗模式:一项回顾性数据库研究。

Patterns of drug treatment in patients with osteoarthritis and chronic low back pain in Japan: a retrospective database study.

作者信息

Akazawa Manabu, Mimura Wataru, Togo Kanae, Ebata Nozomi, Harada Noriko, Murano Haruka, Abraham Lucy, Fujii Koichi

机构信息

Public Health and Epidemiology, Meiji Pharmaceutical University, Tokyo, Japan.

Corporate Affairs, Health & Value, Pfizer Japan Inc., Tokyo, Japan.

出版信息

J Pain Res. 2019 May 21;12:1631-1648. doi: 10.2147/JPR.S203553. eCollection 2019.

Abstract

Musculoskeletal diseases, including osteoarthritis (OA) and low back pain (LBP), are the leading causes of years lived with disability, and are associated with lowered quality-of-life, lost productivity, and increased healthcare costs. However, information publicly available regarding the Japanese real-world usage of prescription medications is limited. This study aimed to describe the clinical characteristics of patients with OA and chronic LBP (CLBP), and to investigate the patterns of medications and opioid use in Japanese real-world settings. A retrospective study was conducted using a Japanese administrative claims database between 2013 and 2017. The outcomes were patient characteristics and prescription medications, and they were evaluated separately for OA and CLBP. The mean age of 118,996 patients with OA and 256,402 patients with CLBP was 68.8±13.1 years and 64.8±16.4 years, respectively. Approximately 90% of patients with OA and CLBP were prescribed non-steroidal anti-inflammatory drugs (NSAIDs). Other prescriptions included hyaluronate injection (35.6%), acetaminophen (21.4%), and steroid injection (20.0%) in patients with OA, and pregabalin (39.0%) and acetaminophen (22.4%) in patients with CLBP. Weak opioids were prescribed to 10.7% and 20.6% of patients with OA and CLBP, respectively. The prescription of COX-2 inhibitors (OA: +6.5%; CLBP: +6.7%) and acetaminophen (OA: +16.4%; CLBP: +14.4%) increased between 2013 and 2017. The first commonly prescribed medication among patients with OA and CLBP were NSAIDs; hyaluronate injection (patients with OA) and pregabalin (patients with CLBP) were also common first-line medications. Acetaminophen, steroid injection (patients with OA), and weak opioids were prescribed more in the later phases of treatment. Most patients were prescribed limited classes of pain drugs, with NSAIDs being the most common pain medication in Japan for patients with OA and CLBP. Opioid prescription was uncommon, and were weak opioids when prescribed.

摘要

肌肉骨骼疾病,包括骨关节炎(OA)和腰痛(LBP),是导致残疾生存年数的主要原因,并且与生活质量下降、生产力丧失以及医疗成本增加相关。然而,关于日本处方药实际使用情况的公开信息有限。本研究旨在描述OA和慢性腰痛(CLBP)患者的临床特征,并调查日本实际环境中药物使用模式和阿片类药物使用情况。使用日本行政索赔数据库在2013年至2017年期间进行了一项回顾性研究。结局为患者特征和处方药,分别对OA和CLBP进行评估。118,996例OA患者和256,402例CLBP患者的平均年龄分别为68.8±13.1岁和64.8±16.4岁。大约90%的OA和CLBP患者被开具非甾体抗炎药(NSAIDs)。其他处方包括OA患者中的透明质酸注射(35.6%)、对乙酰氨基酚(21.4%)和类固醇注射(20.0%),以及CLBP患者中的普瑞巴林(39.0%)和对乙酰氨基酚(22.4%)。分别有10.7%和20.6%的OA和CLBP患者被开具弱阿片类药物。2013年至2017年期间,COX-2抑制剂(OA:+6.5%;CLBP:+6.7%)和对乙酰氨基酚(OA:+16.4%;CLBP:+14.4%)的处方量有所增加。OA和CLBP患者中最常开具的第一种药物是NSAIDs;透明质酸注射(OA患者)和普瑞巴林(CLBP患者)也是常见的一线药物。对乙酰氨基酚、类固醇注射(OA患者)和弱阿片类药物在治疗后期开具得更多。大多数患者被开具的止痛药物种类有限,NSAIDs是日本OA和CLBP患者最常见的止痛药物。阿片类药物处方不常见,开具时多为弱阿片类药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc4f/6535438/7b3d9462beab/JPR-12-1631-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验